Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2

Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2

Background: Coronavirus disease 2019 (COVID-19) is now a worldwide public health crisis. The causative pathogen is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Novel therapeutic agents are desperately needed. Because of the frequent mutations in the virus and its ability to cause cy...

Full description

Bibliographic Details
Main Authors: Wenjiang Zheng, Xiufang Huang, Yanni Lai, Xiaohong Liu, Yong Jiang, Shaofeng Zhan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Pharmacology
Subjects:
coronavirus disease 2019
SARS-CoV-2
glycyrrhizic acid
network pharmacology
inflammatory pathways
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.631206/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.631206/full

Similar Items